japanja
When will corona be a beer again?

When will corona be a beer again?

16-04-2021 | Graph of the week

Not so very long ago, corona was first and foremost a popular and refreshing Mexican beer. But for more than a year, we have been living with the virus and the disease, with large parts of the world still dealing with the resulting lockdowns and inundated hospitals. Fortunately, there’s light at the end of the tunnel: we have started vaccinating people. How are the different developed and emerging countries doing?

  • Jaap  van der Hart
    Jaap
    van der Hart
    Equity Fund Manager
Source: Our World in Data

Israel is leading the way, with more than 60% of the population having been vaccinated, and life for those who have had shots is more or less back to normal. Images of jubilant people filling terraces in Tel Aviv have featured frequently in the news recently. Things are also going well in the US and the UK, both of which started their vaccination program relatively early. EU countries are lagging behind, with a current vaccination rate of 16%, yet the pace of vaccinations is now on par.

In emerging countries, vaccination rates and the pace of vaccinations are significantly lower in most cases. Two exceptions are Hungary and Chile. Both countries have a relatively high infection rate, but at the same time have been quick to procure vaccines. Hungary has also procured Russian Sputnik and Chinese Sinopharm vaccines, against EU policy.

And then there are countries where the vaccination rate is still low, but the disease has remained under control. This is true for China, Japan, South Korea and Taiwan. There is less urgency to act fast in these countries, despite this meaning they will need to remain vigilant for longer.

Graph of the week
If a picture is worth 1,000 words, a chart can say it all. Our Graph of the Week gives the top picks from the Robeco Investment Solutions team.
Graph of the week
Overview

Concerns about India and Brazil

But there are also countries where things are going less well. First up is India, a big producer and exporter of vaccines, which has administered more than 100 million vaccine doses. Relative to the total population, however, this is just 7%, while the number of new infections is soaring. The vaccinations are not coming soon enough and lockdowns to curb the new wave seem inevitable, although not everyone seems of aware of the danger considering the recent images of religious festivals. 

Second is Brazil, the country where President Bolsonaro systematically plays down the disease and where there is little to no national prevention policy in place. The virus has hit hard, with high infection and death rates. In terms of vaccinations, Brazil is doing a little better than some other emerging countries, but the policy response has been inadequate there too, as the country has put too much focus on AstraZeneca, and missed other options. Given the severity of the disease, more vaccinations are desperately needed. 

Other emerging countries have shown a mixed picture but, with a few exceptions, are lagging behind the Western world in the roll-out of vaccines. A resurgence of virus infections remains a risk, also for countries where the infection rate is currently relatively low.

In the West, we hope to have vaccinated enough people by the summer to start returning to normal life. Large Asian countries such as Japan, China and Korea are lagging behind in terms of vaccinations, but Covid-19 is much better under control there. Vaccinations are being administered in the rest of the world too, but at a much slower pace. And in several countries, new infections are still high. 

So, while pavement cafés in some countries will be allowed to reopen soon, corona will primarily remain a serious and impactful disease for a large part of the global population this year.

重要事項

当資料は情報提供を目的として、Robeco Institutional Asset Management B.V.が作成した英文資料、もしくはその英文資料をロベコ・ジャパン株式会社が翻訳したものです。資料中の個別の金融商品の売買の勧誘や推奨等を目的とするものではありません。記載された情報は十分信頼できるものであると考えておりますが、その正確性、完全性を保証するものではありません。意見や見通しはあくまで作成日における弊社の判断に基づくものであり、今後予告なしに変更されることがあります。運用状況、市場動向、意見等は、過去の一時点あるいは過去の一定期間についてのものであり、過去の実績は将来の運用成果を保証または示唆するものではありません。また、記載された投資方針・戦略等は全ての投資家の皆様に適合するとは限りません。当資料は法律、税務、会計面での助言の提供を意図するものではありません。

ご契約に際しては、必要に応じ専門家にご相談の上、最終的なご判断はお客様ご自身でなさるようお願い致します。

運用を行う資産の評価額は、組入有価証券等の価格、金融市場の相場や金利等の変動、及び組入有価証券の発行体の財務状況による信用力等の影響を受けて変動します。また、外貨建資産に投資する場合は為替変動の影響も受けます。運用によって生じた損益は、全て投資家の皆様に帰属します。したがって投資元本や一定の運用成果が保証されているものではなく、投資元本を上回る損失を被ることがあります。弊社が行う金融商品取引業に係る手数料または報酬は、締結される契約の種類や契約資産額により異なるため、当資料において記載せず別途ご提示させて頂く場合があります。具体的な手数料または報酬の金額・計算方法につきましては弊社担当者へお問合せください。

当資料及び記載されている情報、商品に関する権利は弊社に帰属します。したがって、弊社の書面による同意なくしてその全部もしくは一部を複製またはその他の方法で配布することはご遠慮ください。

商号等: ロベコ・ジャパン株式会社  金融商品取引業者 関東財務局長(金商)第2780号

加入協会: 一般社団法人 日本投資顧問業協会

本記事に関連するテーマ: